Tag: vaccine

Extra COVID-19 vaccine may help protect transplant patients

Fox News Flash top headlines for June 15 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. A small study offers the first hint that an extra dose of COVID-19 vaccines just might give some organ transplant recipients a needed boost in protection. Even as most vaccinated people celebrate a return

EXPLAINER: How vaccine passports for global travel will work

Boarding pass, suitcase, passport and … digital vaccination certificate? Keen to avoid losing another summer of holiday revenue to the coronavirus pandemic, the European Union, some Asian governments and the airline industry are scrambling to develop so-called COVID-19 vaccine passports to help kickstart international travel. They’re working on systems that would allow travelers to use

Few SARS-CoV-2 vaccine breakthrough infections reported at SNFs

(HealthDay)—Few cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have been reported at skilled nursing facilities (SNFs) among those with at least 14 days since receipt of the second dose of a two-dose COVID-19 vaccine series, according to research published in the April 21 early-release issue of the U.S. Centers for Disease Control

Pre-Clinical Vaccine Adjuvant and Therapeutics Manufacturing

Analytik reports how its Microfluidizer® processors are enabling researchers develop a range of therapeutic formulations including vaccine adjuvants, liposomes and lipid nanoparticles. By reducing particle size uniformly, Microfluidizers from Analytik are helping a growing number of pharmaceutical companies and Contact Development and Manufacturing Organisations (CDMOs) improve the efficacy, bioavailability, stability and process efficiency of their

J&J ‘very confident’ in vaccine, eyes quick resolution

Johnson & Johnson remains “very confident” in its COVID-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday. “We remain very confident and very hopeful that the benefit-risk profile will play out,” J&J Chief Financial Officer Joseph Wolk told CNBC. The comments came ahead of a decision

China trials mixing of CanSinoBIO's and Zhifei Longcom's COVID-19 vaccines -data

BEIJING (Reuters) -Chinese researchers are testing the mixing of COVID-19 vaccine doses developed by CanSino Biologics and a unit of Chongqing Zhifei Biological Products, according to clinical trial registration data.FILE PHOTO: A logo of China’s vaccine specialist CanSino Biologics Inc is pictured on the company’s headquarters in Tianjin, following an outbreak of the coronavirus disease

CureVac’s COVID-19 Vaccine Attracts Rising Interest

FRANKFURT (Reuters) – German biotech firm CureVac said it has seen the number of requests for its experimental COVID-19 vaccine increase over the past few days, as concerns over rare side effects have hit some other coronavirus shots. A CureVac spokesman said on Thursday that requests have been coming in from various quarters, including governments

Pfizer CEO says a THIRD Covid vaccine may be needed

BREAKING NEWS: Pfizer CEO says a THIRD Covid vaccine dose will be needed as soon as six months after someone receives two shots – and then be vaccinated annually Pfizer CEO Albert Bourla said it is ‘likely’ people will need a booster shot of the COVID-19 vaccine The potential booster shot will be given within

US J&J Covid vaccine pause continues after experts defer vote

A pause on all US vaccinations with the Johnson & Johnson COVID shot will continue for at least another week after members of a government-convened expert panel said Wednesday they needed more time to assess its possible links to a clotting disorder. The Centers for Disease Control and Prevention (CDC) convened a meeting a day

Updated Moderna vaccines neutralize South African SARS-CoV-2 variant in mice

Researchers in the United States have conducted a pre-clinical study demonstrating the efficacy of two updated versions of the Moderna mRNA-1273 vaccine against variants of severe acute respiratory syndrome coronavirus 2 – the agent that causes coronavirus disease 2019 (COVID-19). Study: Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice

Australia Reports Second AstraZeneca Blood Clot Case

SYDNEY (Reuters) – Australia said on Tuesday a second person had been diagnosed with a blood clot after receiving the AstraZeneca Plc vaccine but there had been no rise in inoculation cancellations as authorities try to steady a bungled immunisation campaign. This week Australia abandoned a goal of vaccinating all of its nearly 26 million